Cervical cancer in Latin America and the Caribbean: The problem and the way to solutions

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 9, 2012, Pages 1409-1413

  Villa, Luisa Lina ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

CANCER IMMUNIZATION; CANCER MORTALITY; CANCER SCREENING; CENTRAL AMERICA; EDUCATIONAL STATUS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; PAPANICOLAOU TEST; PRIORITY JOURNAL; REVIEW; SOCIAL STATUS; SOUTH AND CENTRAL AMERICA; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS;

CARIBBEAN REGION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LATIN AMERICA; MALE; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84866180973     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0147     Document Type: Review

References (30)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer incidence and mortality Worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010 [cited 2012 Mar 12]. Available from: http://globocan.iarc.fr
2. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 2006;24 Suppl 3, S11-25.
3. Parkin DM, Almonte M, Bruni L, Clifford G, Curado MP, Pineros M. Burden and trends of type-specific human papillomavirus infections and related diseases in the Latin America and Caribbean region. Vaccine 2008;26 Suppl 11:L1-15.
4. WHO/ICO information centre on HPV and cervical cancer (HPV information centre). Human papillomavirus and related cancers in Americas. Summary report 2010; [cited 2012 Mar 12]. Available at www.who.int/hpvcentre.
5. Murillo R, Almonte M, Pereira A, Ferrer E, Gamboa OA, Jerónimo J, et al. Cervical cancer screening programs in Latin America and the Caribbean. Vaccine 2008;26 Suppl 11:L37-48.
6. PAHO plan of action for cervical cancer prevention and control. [cited 2011 Dec 15]. Available from: http://www.paho.org/english/ad/dpc/nc/pcc- proposed-plan.pdf.
7. Winkler JL, Wittet S, Bartolini RM, Creed-Kanashiro HM, Lazcano-Ponce E, Lewis-Bell K, et al. Determinants of human papillomavirus vaccine acceptability in Latin America and the Caribbean. Vaccine 2008;26 Suppl 11:L73-9.
8. Moreira ED Jr, Oliveira BG, Ferraz FM, Costa S, Costa Filho JO, Karic G. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention. Int J Gynecol Cancer 2006;16:599-603.
9. Rama CH, Villa LL, Pagliusi S, Andreoli MA, Costa MC, Aoki AL, et al. Awareness and knowledge of HPV, cervical cancer, and vaccines in young women after first delivery in São Paulo, Brazil-a cross-sectional study. BMC Womens Health 2010;10:35.
10. Almonte M, Murillo R, Sánchez GI, Jerônimo J, Salméron J, Ferreccio C, et al. New paradigms and challenges in cervical câncer prevention and control in Latin América. Salud Pub Mex 2010;52:544-59.
11. Murillo R, Wiesner C, Cendales R, Pineros M, Tovar S. Comprehensive evaluation of cervical câncer screening programs: the case of Colombia. Salud Pub Mex 2011;53:469-77.
12. Herrero R, Ferreccio C, Salmerón J, Almonte M, Sánchez GI, Lazcano-Ponce E, et al. New approaches to cervical cancer screening in Latin America and the Caribbean. Vaccine 2008;26 Suppl 11:L49-58.
13. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011;103:368-83.
14. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008;26 Suppl 10:K29-41.
15. Longatto-Filho A, Erzen M, Branca M, Roteli-Martins C, Naud P, Derchain SF, et al. Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study. Int J Gynecol Cancer 2006;16:955-62.
16. Syrjanen K, Naud P, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, et al. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study. Anticancer Res 2005;25:3469-80.
17. Flores YN, Bishai DM, Lorincz A, Shah KV, Lazcano-Ponce E, Hernández M, et al. HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico. Cancer Causes Control 2011;22:261-72.
18. Ferreccio C, Corvalán A, Margozzini P, Viviani P, González C, Aguilera X, et al. Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples. BMC Public Health 2008;8:78.
19. Holanda F Jr, Castelo A, Veras TM, de Almeida FM, Lins MZ, Dores GB. Primary screening for cervical cancer through self-sampling. Int J Gynaecol Obstet 2006;95:179-84.
20. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmerón J, Uribe P, Velasco-Mondragón E, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet 2011;378:1868-73.
21. Villa LL. HPV prophylactic vaccination: The first years and what to expect from now. Cancer Lett 2011;305:106-12.
22. Perez G, Lazcano-Ponce E, Hernandez-Avila M, García PJ, Muñoz N, Villa LL, et al. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women. Int J Cancer 2008;122:1311-8.
23. Ciapponi A, Bardach A, Glujovsky D, Gibbons L, Picconi MA. Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis. PLoS One 2011;6:e25493.
24. Lee FH, Paz-Soldan VA, Carcamo C, Garcia PJ. Knowledge and attitudes of adult peruvian women vis-à-vis Human Papillomavirus (HPV), cervical cancer, and the HPV vaccine. J Low Genit Tract Dis 2010;14:113-7.
25. Penny M, Bartolini R, Mosqueira NR, LaMontagne DS, Mendoza MA, Ramos I, et al. Strategies to vaccinate against cancer of the cervix: feasibility of a school-based HPV vaccination program in Peru. Vaccine 2011;29:5022-30.
26. Lazcano-Ponce E, Pérez G, Cruz-Valdez A, Zamilpa L, Aranda-Flores C, Hernández-Nevarez P, et al. Impact of a quadrivalent HPV6/11/16/18 vaccine in Mexican women: public health implications for the region. Arch Med Res 2009;40:514-24.
27. Arrossi S, Maceira V, Paolino M, Sankaranarayan R. Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: A population-based survey. Vaccine 2012;23;30:2467-74.
28. Franco EL, Tsu V, Herrero R, Lazcano-Ponce E, Hildesheim A, Muñoz N, et al. Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean. Vaccine 2008;26 Suppl 11:L88-95.
29. Muñoz N, Franco EL, Herrero R, Andrus JK, de Quadros C, Goldie SJ , et al. Recommendations for cervical cancer prevention in Latin America and the Caribbean. Vaccine 2008;26 Suppl 11:L96-107.
30. Center for Disease Control and Prevention (CDC). Progress toward implementation of human papillomavirus vaccination-the Americas, 2006-2010. MMWR Morb Mortal Wkly Rep 2011;60:1382-4.